Join the ISPE Gulf Regional Interest Group for an exclusive Virtual Symposium: Real World Evidence and the Future of Health Technology Regulation.
🔗 Register here: https://t.co/h3qMTdkv6s (Limited Seats).
#RWE#RWD#HTA#FDA
As Real-World Evidence (RWE) becomes more central to decision making, we also need stronger tools to handle bias.
Join ISPE-GRIG for a webinar on Propensity Scores Methods
🗓 Dec 8, 2025
⏱️ 2 PM (Riyadh)
💻 Zoom
🔗 Register: https://t.co/cKX2BE3a76
#RWE#RWD#ISPE
The webinar is open to all interested participants.
Don't miss this opportunity to gain valuable insights into real-world evidence research from both international and Gulf region perspectives.
We look forward to seeing everyone in this enlightening session!
#ISPEGRIG is delighted to invite you to the webinar "Real-World Evidence Research: International and Gulf Region Experience".
🗓️ Wednesday, March 6, 2024
🕒 3:00 - 4:00 PM Riyadh time
📍Online via Zoom
Registration link: https://t.co/bbJMBX6Wr0
#ISPEGRIG is pleased to invite you to register and attend“Measure of frequency and association in epidemiology“led by Dr. @Research_Easy
📆Tuesday,March 8,2022
🕗8:00pm
📍Zoom meeting
Registration is open to anyone & everyone who is interested!
Join us:https://t.co/7DQzBxwXz6
#ISPEGRIG is pleased to invite you to register and attend“Measure of frequency and association in epidemiology“led by Dr. @Research_Easy
📆Tuesday,March 8,2022
🕗8:00pm
📍Zoom meeting
Registration is open to anyone & everyone who is interested!
Join us:https://t.co/7DQzBxwXz6
#ISPEGRIG is pleased to invite you to register and attend“Measure of frequency and association in epidemiology“led by Dr. @Research_Easy
📆Tuesday,March 8,2022
🕗8:00pm
📍Zoom meeting
Registration is open to anyone & everyone who is interested!
Join us:https://t.co/7DQzBxwXz6
Research title: Olanzapine and Potential Risk of Somnambulism : Causality Assessment of Cases. (Poster Presentation)
Presenter: Saja Alhabardi
Institution: @Saudi_FDA
Coauthors: Waad Altayyar, Nouf Al-Fadel and Fawaz Alharbi
Research title: Saudi FDA-Approved Risk Minimization Measures: A Descriptive Overview. (Spotlight Poster Presentation)
Presenter: Yasser Albogami
Institution: @_KSU
Coauthors: Sultan Alshehri and Abdullah Alkhaibri